On May 21, the “Friendly and Amicable·Great Love Hunan” My Dream public welfare performance and Hunan Science and Technology Disability Assistance Products Exhibition was held in Changsha. Dianxun Li, Deputy Secretary of Hunan Provincial Committee of the CPC, Xiuming Zhong, Vice Chairman of China Disabled Persons’ Federation, Xusheng Hu, Deputy Director of the Standing Committee of Hunan Provincial People’s Congress, and Weilin Hu, Vice Chairman of the Hunan Provincial Committee of the Chinese People’s Political Consultative Conference, were present to watch the performance. The public welfare performance was jointly sponsored by Hunan Disabled Persons’ Federation and China Special Art Direction Center for the Disabled. The performance was one of the series of activities of the 34th National Help-the-disabled Day in Hunan Province.
Before the opening of the performance, Dianxun Li and his entourage visited the representatives of the China Disabled People’s Performing Art Troupe and visited the Exhibition of Science and Technology Products for the Disabled. Accompanied by Huakai Yin, Secretary of the Party Group and Chairman of the Hunan Disabled Persons’ Federation, and Bang Chen, Chairman of Aier Eye Hospital Group, Dianxun Li and his entourage visited the booth of IntelliMicro, where he learned in detail about the principles of the series products, service groups and company development, and fully affirmed the innovation, practicability and accessibility of IntelliMicro’s series of high-end medical device products.
（Dianxun Li, Deputy Secretary of Hunan Provincial Committee of the CPC, interacted with the personnel of IntelliMicro）He pointed out that IntelliMicro should continue to give full play to its own advantages in technology, resources and products, and cooperate with more high-tech medical companies in Hunan such as Aier Eye Hospital, strengthen exchanges and cooperation, promote win-win development, so as to make more and better high-tech products benefit the disabled, improve their quality of life, and provide strong support for helping them participate in social activities equally and conveniently.It is reported that the exhibition gathered dozens of domestic top science and technology disability assistance products, respectively, from multiple dimensions such as visual aids, hearing aids, walking aids, etc., to show the scientific and technological innovation achievements in the field of disability services. IntelliMicro has always adhered to the development concept of “Dreams of disabled made possible by Microtechnology”, and the products exhibited such as “IntelliMicro® Rebound Tonometer” and “IMIE intelligent vision implant” have attracted much attention.IntelliMicro® Rebound Tonometerglaucoma has become the world’s first irreversible eye disease which lead to blindness, due to the insidious onset of glaucoma, insufficient popularization of science, insufficient attention, and limited intraocular pressure detection methods, 90% of glaucoma patients in China do not know that they have glaucoma, and have never even heard of glaucoma. In fact, blindness caused by glaucoma is preventable and controllable. If early detection and early treatment are achieved, and household intraocular pressure (IOP) monitoring is carried out, the blindness can be delayed, and the blindness rate can be greatly reduced. It is understood that there are currently nearly 6 million people blinded by glaucoma in China, and the vast majority of them are caused by late detection and delay the best treatment time.However, many people also have misunderstandings about IOP testing, such as thinking that the IOP can be determined by a single outpatient IOP test result, and the IOP values of both eyes are normal as long as the values are within the normal range (10-21mmHg). In fact, due to the volatility and rhythmicity of IOP, a single outpatient IOP test cannot adequately reflect the real changes in IOP. At the same time, the normal IOP range should not only be within 10-21mmHg, but also the difference between both eyes should not exceed 5mmHg, and the fluctuation of each eye should not exceed 8mmHg within 24 hours. The above cognitive misunderstandings can easily lead to misjudgment and even missed diagnosis of IOP problems, which will delay the treatment.Currently, the “24-hour Gold Standard IOP Monitoring” is widely accepted and recommended in clinical practice, which can effectively reduce the missed diagnosis rate. In response to the Chinese market demand, IntelliMicro has grandly launched a new type of rebound tonometer - IntelliMicro® Rebound Tonometer with its advantages of Chinese and overseas technical resources, which is a medical/household, self-test, handheld professional medical device of Category Ⅱ. The product can meet the user’s 24-hour IOP monitoring needs, and provides a more economical, fast and convenient real-time IOP detection method IOP abnormalities, glaucoma and for the postoperative treatment evaluation for ophthalmic patients, as well as doctors’ diagnosis and treatment, filling the gap of domestic self-test household tonometer.IMIE Intelligent Vision Implant“IMIE Inteliigent Vision Implant” is the first-launched project of IntelliMicro’s neuro-modulation technology in the world, and is an innovative medical device for the treatment of severe to deep retinitis pigmentosa. The project is the first medical device project registered under the rare disease channel in China, and belongs to active implantable medical devices of Category Ⅲ. The project is currently the only effective means in the world to help blind people restore their sight, which can effectively help blind people improve their quality of life, and is currently in the clinical trial stage.
